Valiant Co

Valiant Co EV/EBITDA

The EV/EBITDA (Enterprise Value to EBITDA) of Valiant Co (002643.SZ) as of Nov 19, 2026 is 32.27. In the previous year, EV/EBITDA (Enterprise Value to EBITDA) was 32.18 — a change of 0.29% (higher).

EV/EBITDA

32.27

YoY

0.29%

Last updated:

EV/EBITDA (Enterprise Value to EBITDA) of Valiant Co is 2025 32.27 . EV/EBITDA (Enterprise Value to EBITDA) of Valiant Co was 2024 32.18 . It decreases by 0.29% higher compared to the previous year.

The Valiant Co EV/EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/EBITDA
Date
EV/EBITDA
Jan 1, 2018
27.24 CNY
Jan 1, 2019
22.55 CNY
Jan 1, 2020
21.81 CNY
Jan 1, 2021
17.64 CNY
Jan 1, 2022
14.34 CNY
Jan 1, 2023
15.41 CNY
Jan 1, 2024
32.18 CNY
Jan 1, 2025
32.27 CNY
The Valiant Co EV/EBITDA history
YEAREV/EBITDAYoY
32.27+0.29%
32.18+108.85%
15.41+7.42%
14.34-18.70%
17.64-19.13%
21.81-3.27%
22.55-17.22%
27.24-16.34%
32.56-18.67%
40.04-17.72%
48.66-64.30%
136.32—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valiant Co Stock analysis

What does Valiant Co do? Valiant Co., Ltd. generates revenue through three core business segments. The Information Materials Industry segment produces and sells display materials and functional materials, targeting customers in the electronics and manufacturing sectors. The Environmental Protection Materials Industry segment develops and manufactures new zeolite environmental protection materials for tail gas purification, serving automotive and industrial clients requiring emission control solutions. The Large Health Industry segment focuses on pharmaceutical production, life sciences, and in vitro diagnostic services, catering to healthcare providers and medical facilities. The company's products include display materials, functional materials, new zeolite environmental protection materials, pharmaceuticals, and in vitro diagnostic services. These offerings are sold across the three industry segments, with the Environmental Protection Materials segment specifically addressing tail gas purification needs. The Large Health Industry segment's in vitro diagnostic services support healthcare operations through specialized medical solutions. Valiant Co., Ltd. serves diverse customer segments including electronics manufacturers, automotive industries, industrial emission control clients, and healthcare providers. The firm's revenue streams are derived from the sale of physical products like display materials and zeolite materials, as well as service-based offerings in diagnostics and pharmaceuticals. The company's business model relies on manufacturing and selling these products across its three operational segments. Valiant Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Valiant Co stock

EV/EBITDA (Enterprise Value to EBITDA) of Valiant Co is 32.27 in 2025.

EV/EBITDA (Enterprise Value to EBITDA) of Valiant Co changed from 32.18 to 32.27, representing a 0.29% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EV/EBITDA (Enterprise Value to EBITDA) Valiant Co since 2006 – with annual values, charts, and detailed analysis.

The EV/EBITDA ratio is a widely used valuation metric that compares a company's enterprise value to its EBITDA. It normalizes for differences in capital structure, taxation, and depreciation policies.

To evaluate EV/EBITDA (Enterprise Value to EBITDA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/EBITDA (Enterprise Value to EBITDA).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/EBITDA (Enterprise Value to EBITDA)'s Valiant Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Valiant Co

All Key Metrics — Valiant Co